$BLPH- L: $1.30. BIOTECHNOLOGY.
SUPPORT LEVEL AT $1.25. RESISTANCE LEVEL AT $1.55.
AFTERHOURS: SLIGHTLY UP FROM CLOSE PRICE.
RELEVENT NEWS: 01/04/17 http://seekingalpha.com/news/3233395-fda-oks-changes-bellerophons-late-stage-program-inopulse-pah-may-cut-time-market-t
PROS: RECENT RUN UP ON PRICE ACTION AND VOLUME ON A DAILY CHART. GOOD NEWS. HAS GOOD SPIKING PRICE ACTION IN THE PAST. SPIKE COULD CONTINUE LONGER. DECENT SHARE STATISTICS. SUPERNOVA TYPE SET UP. OFF HIGHS.
CONS: LARGE RED DAY AS LAST TICK. HORRIBLE COMPANY LONGTERM VALUE. BIOTECH COMPANY SO WATCH OUT. 0% PROFIT MARGIN. BAD FUNDEMENTALS. TESTING A LOT OF LONGTERM RESISTANCE. BE CAREFUL AS PRICE TENDS TO FALL FAST AS THE PAST INDICATES.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF IT CAN BREAK SHORT-TERM RESISTANCE AT $1.55, THEN I WOULD WANT TAKE A POSITIVE POSITION IF PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.50 - $1.00. SIZE: MID
$DCTH- L: $0.19. DRUG MANUFACTURERS.
SUPPORT LEVEL AT $0.15. RESISTANCE LEVEL AT $0.21.
AFTERHOURS: CONSOLODATING AROUND CLOSE PRICE.
RELEVENT NEWS: 01/22/17 http://www.streetinsider.com/Corporate+News/Delcath+Systems+%28DCTH%29+Says+Published+Review+Shows+Its+Investigational+PHP+Doubles+Overall+Survival+Over+Other+Targeted+Liver+Therapies/12576941.html
PROS: GAINING A LOT OF VOLUME. HAS BEEN VOLATILE LATELY. GOOD NEWS. DECENT SHARE STATISTICS. PRICE ATION LOOKS LIKE IT COULD BE SET FOR A RISE. THEY DO HAVE SOME CASH, BUT OVERALL MORE DEBT AND BAD RETURNS. IF IT CAN PICK UP MAY BE A SUPERNOVA MULTI-RUNNER TYPE SETUP.
CONS: HORRIBLE FUNDEMENTALS. HASN'T PICKED UP ENOUGH IN LONGTERM PRICE ATION. 0% PROFIT MARGIN. A LOT OF RED VOLUME. HAS A NASTY HABBIT OF FALLING VERY QUICKLY IN THE PAST. BEEN CONSOLODATING FOR ABOUT 2 YEARS.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF IT CAN BREAK SHORT-TERM RESISTANCE AT $0.21 I WILL TAKE A POSITIVE POSITION IF PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.05 - $0.10. SIZE: SMALL-MID
$NAK- L: $1.82. INDUSTRIAL METALS & MINERALS.
SUPPORT LEVEL AT $1.30. RESISTANCE LEVEL AT $2.30.
AFTERHOURS: UP NICELY FROM CLOSE PRICE.
RELEVENT NEWS: 02/21/17 http://www.businesswire.com/news/home/20170221006630/en/
PROS: GAINING A LOT OF VOLUME ON A DAILY CHART. WELL OFF HIGHS. IT SHOWS IN THE PAST THAT IT CAN SPIKE FAIRLY LARGE. UP AFTERHOURS. COULD BE A SHORT SQUEEZE SET UP. MAY BE A BOTTOM.
CONS: MOST VOLUME IS RED. FALLING KNIFE PATTERN. HIGH FLOAT. BAD FUNDEMENTALS. FALLS FAST AND HARD. NEEDS MORE POSITIVE PRICE ATION BEFORE A TRADE COULD BE CONSIDERED. IN A CLASS ATION LAWSUIT.
TARGET: DAY TRADE. LONG/SHORT TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM RESISTANCE OF $2 I WILL TAKE A POSITIVE POSITION IF PRICE ATION AND VOLUME SUPPORT MY DECISION AT THE TIME. IF THE PRICE CAN BREAK SHORT-TERM SUPPORT AT $1.40 I WILL TAKE A NEGATIVE POSITION IF THE PRICE ATION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.50. SIZE: SMALL
$EYEG- L: $2.55. BIOTECHNOLOGY.
SUPPORT LEVEL AT $2.50. RESISTANCE LEVEL AT $3.00.
AFTERHOURS: UP VERY SLIGHTLY AFTERHOURS.
RELEVENT NEWS: 02/22/17 https://secure.blueoctane.net/forms/FKJ3AB16W96E
PROS: HAD HUGE PRICE ATION AND VOLUME BURST. LICENCING DEAL HELPS SUPPORT PRICE ACTION. OFF OF HIGHS. ONE BIG DAY UP AND ONE BIG DAY DOWN. PART OF THE BIOTECH RALLY. NICE DIP BUY SET UP. POSSIBLE DOUBLE TOP PATTERN. DECENT SHARE STATISTICS.
CONS: A LOT OF FADING VOLUME AND NEGATIVE PRICE ATION ON IT'S LAST TRADING DAY. 0% PROFIT MARGIN. BAD FUNDEMENTALS W/ SOME CASH.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM RESISTANCE LEVEL OF $3.00 I WILL TAKE A POSITIVE POSITION IF THE PRICE ATION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.50. SIZE: MID
$MBOT- L: $7.42. MEDICAL INSTRUMENTS & EQUIPMENT.
SUPPORT LEVEL AT $7.00. RESISTANCE LEVEL AT $8.00.
AFTERHOURS: CONSOLODATING NEAR CLOSE PRICE.
RELEVENT NEWS: 02/22/17 http://www.streetinsider.com/Corporate+News/Microbot+Medical+%28MBOT%29+Announces+Significant+U.S.+Technology+Patent+Allowance/12576493.html
PROS: HAD HUGE PRICE ACTION AND VOLUME BURST. TECHNOLOGY PATENT ALLOWANCE NEWS. VERY VOLATILE. PAST SHOWS THAT THIS TICKER CAN SPIKE HUGE FAST. DECENT SHARE STATISTICS. DOWN OFF OF HIGHS. POSSIBLE SUPERNOVA OR MULT-DAY RUNNER SET UP.
CONS: HORRIBLE FUNDEMENTALS. 0% PROFIT MARGIN. HAS GAPPED DOWN DRASTICALLY IN THE PAST. WOULD LIKE TO SEE MORE PRICE ATION BEFORE CONSIDERING A TRADE.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM RESISTANCE LEVEL OF $8.00 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $1.00. SIZE: MID-LARGE
$GIGL- L:$0.0859. RESTAURANTS.
SUPPORT LEVEL AT $0.77. RESISTANCE LEVEL AT $0.95.
AFTERHOURS: NO CHANGE.
RELEVENT NEWS: 02/22/17 http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=30342112
PROS: HAD HUGE PRICE ATION AND VOLUME BURST. POSSIBLE MULTI-DAY RUNNER. MERGER NEWS. POSSIBLE SUPERNOVA OR MULT-DAY RUNNER SET UP. DECENT SHARE STATISTICS. HUGE AMOUNT OF VOLUME ON LONGTERM CHART. VERY VOLATILE.
CONS: HORRIBLE FUNDEMENTALS. -52.11% NEGATIVE PROFIT MARGIN. UP ON HIGHS AND CAN FALL FAST.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM RESISTANCE $0.92 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.30. SIZE: MID-LARGE
$ACCO- L:$14.15. BUSINESS EQUIPMENT.
SUPPORT LEVEL AT $13.80. RESISTANCE LEVEL AT $15.00.
AFTERHOURS: UP NICELY FROM CLOSE PRICE.
RELEVENT NEWS: 02/22/17 http://www.reuters.com/article/brief-acco-brands-corp-reports-q4-adjust-idUSASB0B1HT
PROS: GOOD EARNINGS RESULTS. GOOD RUN UP IN PRICE ACTION. DECENT SHARE STATISTICS. HAS A PROFIT MARGIN OF 7.99%. FUNDEMENTALS ACTUALLY LOOK PRETTY GOOD. DOUBLE TOP PATTERN ON DAILY ON A 10 YEAR CHART. COULD BE A POSSIBLE MULTI-DAY RUNNER.
CONS: VOLUME HAS NOT SPIKED AS MUCH AS I WOULD LIKE TO SEE. IT IS HITTING A LOT OF LONGTERM RESISTANCE AT THE $15 SPOT. UP ON HIGHS. HAS A PEAK AND VALLEY TYPE STYLE AND LOOKS LIKE IT MAY BE OVER EXTENDED. HIGH FLOAT.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK $15 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $1.00. SIZE: SMALL-MID
$CNBX- L: $4.30. BIOTECHNOLOGY.
SUPPORT LEVEL AT $3.40. RESISTANCE LEVEL AT $5.00.
AFTERHOURS: NO CHANGE.
PROS: A BIG RUNNER OFF OF IT'S HIGHS. DECENT SHARE STATISTICS. VOLUME HAS GAINED VERY NICELY OVER THE PAST FEW WEEKS. DIP BUY TYPE SET UP. COULD BE A MULTI-DAY RUNNER.
CONS: HORRIBLE FUNDEMENTALS. HIGH FLOAT. DROPS FAST. UP OFF OF HYPE. DOWN MAJORLY LAST TRADING DAY.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK $5.00 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $1.00. SIZE: MID-LARGE
$CETX- L: $3.57. POLLUTION AND TREATMENT.
SUPPORT LEVEL AT $2.80. RESISTANCE LEVEL AT $4.00.
AFTERHOURS: CONSOLODATING AROUND CLOSE PRICE.
RELEVENT NEWS: 02/16/17 http://www.prnewswire.com/news-releases/cemtrex-warrants-and-preferred-shares-set-to-commence-trading-on-friday-february-17-2017-300408952.html
PROS: A BIG RUNNER OFF OF IT'S HIGHS. A LOT OF VOLUME. LOW FLOAT. GOOD SHARE STATISTICS. PRETTY GOOD FUNDEMENTALS. 5.2% PROFIT MARGIN. AT A POSSIBLE BOTTOM. STRONG TECHNICAL SUPPORT PLAY. DIP BUY. COULD BE A POSSIBLE MULTI-DAY RUNNER.
CONS: MOSTLY RED VOLUME. HAS BEEN DOWN FOR A WHILE. MAY BE A FALLING KNIFE. CAN FALL FAST.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK $4.OO I WILL TAKE A POSITVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.50 - $1.00. SIZE: MID
$CUR- L: $3.84. BIOTECHNOLOGY.
SUPPORT LEVEL AT $3.70. RESISTANCE LEVEL AT $4.30.
AFTERHOURS: CONSOLODATING AROUND CLOSE PRICE.
RELEVENT NEWS: 02/16/17 http://seekingalpha.com/news/3244100-neuralstem-completes-enrollment-mid-stage-study-nsiminus-189-mdd-shares-ahead-19-percent
PROS: GOOD NEWS. GOOD VOLUME AND PRICE ACTION PICK UP ON A DAILY CHART. LOW FLOAT. DECENT SHARE STATISTICS. COULD BE A MULTI-DAY RUNNER. POSSIBLE DOUBLE TOP PATTERN.
CONS: HITTING A LOT OF LONGTERM RESISTANCE SOON. BAD FUNDEMENTALS. 0% PROFIT MARGIN. TENDS TO FALL FAST. ON A DAILY OR MINUTE CHART SPIKES DON'T TEND TO HOLD HIGHS. NEEDS A LITTLE MORE VOLATILITY.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK $4.30 I WILL TAKE A POSITIVE POSTION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.50. SIZE: SMALL
$INAP- L:$2.31. SOFTWARE - APPLICATIONS.
SUPPORT LEVEL AT $1.90. RESISTANCE LEVEL AT $2.50.
AFTERHOURS: CONSOLODATING AROUND CLOSE PRICE.
PROS: LARGE AMOUNTS OF VOLUME GAINED IN THE LAST MONTH OR SO. PRICE ATION HAS BEEN GOOD. POSSIBLE START TO ANOTHER RUN LIKE THE PREVIOUS ONE THIS TICKER HAD LAST MONTH. LARGE GREEN VOLUME TICK RECENTLY. DECENT SHARE STATISTICS. HIGHLY INSTITUIONAL OWNED. POSSIBLE DIP BUY SET UP. POSSIBLE STEP UP TYPE PATTERN.
CONS: HORRIBLE FUNDEMENTALS. HIGH FLOAT. -49.8% NEGATIVE PROFIT MARGIN. CAN FALL FAST AND HARD. UP ON HIGHS.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM RESISTANCE AT $2.50 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.30 - $0.50. SIZE: SMALL
$SNGX- L: $2.38. BIOTECHNOLOGY.
SUPPORT LEVEL AT $2.30. RESISTANCE LEVEL AT $2.60.
AFTERHOURS: NO CHANGE.
RELEVENT NEWS: 02/22/17 http://www.prnewswire.com/news-releases/soligenix-receives-european-patent-for-formulation-of-synthetic-hypericin-to-treat-psoriasis-300410854.html
PROS: RECIEVES PATENT PLAY. REALLY GOOD TICK IN VOLUME. FIRST DAY ACTIVE. COULD BE A MULTI-DAY RUNNER. IS ABLE TO SPIKE A LOT IN THE PAST.
CONS: HORRIBLE FUNDEMENTALS. BAD SHARE STATISTICS. -33.32 NEGATIVE PROFIT MARGIN. FIRST DAY HAS BEEN TRADED HEAVILY IN A WHILE. WOULD LIKE TO SEE MORE VOLATILITY.
TARGET: DAY TRADE. LONG TARGET PERSPECTIVE. HIGHLY SPECULATIVE PLAY. IF THE PRICE CAN BREAK $2.80 I WILL TAKE A POSITIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.30. SIZE: SMALL
$ANTH- L: $0.7224. BIOTECHNOLOGY.
SUPPORT LEVEL AT $0.68. RESISTANCE LEVEL AT $0.85.
AFTERHOURS: NICELY UP FROM CLOSE PRICE.
RELEVENT NEWS: 02/22/17 http://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-031000903.html 02/22/17 http://seekingalpha.com/article/4048371-anthera-pharmaceuticals-now-trading-cash-value-biotech-rise-ashes
PROS: PRICE ACTION HAS BEEN GOOD. HAD A BIG MID-DAY SPIKE LAST TRADING DAY. DAILY CHART LOOKS GOOD FOR VOLUME. COULD BE A POSSILBLE SHORT SQUEEZ SET UP. COULD BE A POSSIBLE DIP BUY.
CONS: HORRIBLE FUNDEMENTALS. BAD SHARE STATISTICS. 0% PROFIT MARGIN. 15.05% SHORT INTREST. IN A LAWSUIT. PRICE GAPS DOWN OFTEN BY A LOT. COULD FALL HARD DUE TO BEARISH OUTLOOK.
TARGET: DAY TRADE. SHORT TARGET PERSPECTIVE. IF THE PRICE CAN BREAK SHORT-TERM SUPPORT OF $0.68 I WILL TAKE A NEGATIVE POSITION IF THE PRICE ACTION AND VOLUME SUPPORT MY DECISION AT THE TIME. MY TARGET GOAL IS $0.30. SIZE: SMALL
OLD RUNNERS TO WATCH OUT FOR
$DRYS
$GLBS
$APRI
Join now or log in to leave a comment